Produto adicionado correctamente ao carrinho.

discount label
H-GWEPDDNPI-OH
Ver 3D

Biosynth logo

H-GWEPDDNPI-OH

Ref. 3D-PP43614

1mg
217,00 €
10mg
253,00 €
100mg
455,00 €
Entrega estimada em Estados Unidos, Sexta-feira 27 de Dezembro de 2024

Informação sobre produto

Nome:
H-GWEPDDNPI-OH
Sinónimos:
  • NH2-Gly-Trp-Glu-Pro-Asp-Asp-Asn-Pro-Ile-OH
Descrição:

Peptide H-GWEPDDNPI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GWEPDDNPI-OH include the following: A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression XT Song , KE Kabler, L Shen, L Rollins, XF Huang - Nature medicine, 2008 - nature.comhttps://www.nature.com/articles/nm1721 Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity V Rigo, MV Corrias, AM Orengo, A Brizzolara - Cancer Immunology , 2014 - Springerhttps://link.springer.com/article/10.1007/s00262-014-1536-9 Survivin minigene DNA vaccination is effective against neuroblastoma S Fest, N Huebener, M Bleeke - journal of cancer, 2009 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.24291 Cry1Ac Protoxin Confers Antitumor Adjuvant Effect in a Triple-Negative Breast Cancer Mouse Model by Improving Tumor Immunity RR Servin-Garrido - Cancer: Basic and , 2022 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/11782234211065154 Treat cancers by targeting survivin: just a dream or future reality? MS Coumar , FY Tsai, JR Kanwar , S Sarvagalla - Cancer treatment , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0305737213000339 Checkpoint blockade in combination with cancer vaccines MA Morse, HK Lyerly - Vaccine, 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X15014723 Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen M Croce , R Meazza, AM Orengo, M Fabbi - Cancer Immunology , 2008 - Springerhttps://link.springer.com/article/10.1007/s00262-008-0496-3 Neuroblastoma: Perspectives for the Use of IL-21 in Immunotherapy M Croce , MV Corrias, S Ferrini - Neuroblastoma: Diagnosis, Therapy, and , 2012 - Springerhttps://link.springer.com/chapter/10.1007/978-94-007-2418-1_12 Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models K Zhu, H Qin, SC Cha, SS Neelapu , W Overwijk - Vaccine, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X07009929 Aedes aegypti midgut DNA synthesis de novo is an essential antiviral strategy against dengue virus serotype 2 replication J Serrato - IMMUNO MEXICO 2018 - academia.eduhttps://www.academia.edu/download/108101289/ALAI_SMI_IMUNOMEXICO_2018.pdf#page=1030 Immunomodulatory monoclonal antibodies combined with peptide vaccination provide potent immunotherapy in an aggressive murine neuroblastoma model EL Williams, SN Dunn, S James, PW Johnson - Clinical cancer , 2013 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/19/13/3545/207430 Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNFalpha E Balza , B Carnemolla, L Mortara - journal of cancer, 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.25018 STING Ligand c-di-GMP Improves Cancer Vaccination D Chandra, AJ Wilber Quispe-Tintaya - academia.eduhttps://www.academia.edu/download/35121430/Chandra_STING_ligand_improve_cancer_vaccine.pdf STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer D Chandra , W Quispe-Tintaya , A Jahangir - Cancer immunology , 2014 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/2/9/901/467559 Excreted/secreted products from a helminth parasite inhibits tumorigenesis on the early stages of colitis associated colorectal cancer BEC Piaca±a, SR Martaca­nez, I Chavez, CDacaSB Soto - IMMUNO MEXICO - researchgate.nethttps://www.researchgate.net/profile/Elizabeth_Salinas_Estrella/publication/328389976_Antibodies_generated_against_bovine_CD205_using_a_bioinformatics_approach/links/5bca0548458515f7d9cb8310/Antibodies-generated-against-bovine-CD205-using-a-bioinformatics-approach.pdf#page=1042 Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of A NoeDominguez-Romero - Human Vaccines & , 2014 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/hv.29679 Immunotherapy with Listeria reduces metastatic breast cancer in young and old mice through different mechanisms A Jahangir , D Chandra , W Quispe-Tintaya - , 2017 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2017.1342025 Therapy with multi-epitope virus-like particles of B19 parvovirus reduce tumor growth and lung metastasis in an aggressive breast cancer mouse model A de Jesus Jimenez-Chavez , L Moreno-Fierros - Vaccine, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X19312964

Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:

Propriedades químicas

MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:

Informação sobre riscos

Número ONU:
EQ:
Classe:
Frases H:
Frases P:
Proibido de voar:
Informação sobre riscos:
Grupo de Embalagem:
LQ:

Consulta técnica sobre: 3D-PP43614 H-GWEPDDNPI-OH

Por favor, utilize o carrinho para solicitar um orçamento ou uma encomenda

Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.

* Campos obrigatórios
Bem-vindo à CymitQuimica!Usamos cookies para melhorar sua visita. Não incluímos publicidade.

Consulte a nossa Política de Cookies para mais detalhes ou ajuste suas preferências em "Configurar".